EYPT
EYPT
NASDAQ · Pharmaceuticals

Eyepoint Inc

$14.63
+0.25 (+1.74%)
As of Jun 24, 2:05 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -37.0% upside
Low Target $6.71
Average Target $9.21
High Target $14.14
Current Price $14.63
Current
$14.63
Target
$9.21
$6.71 $9.21 avg $14.14
Scenario Analysis
Bear Case
$6.71
-54.1%
Low target
Base Case
$9.21
-37.0%
Avg target
Bull Case
$14.14
+-3.3%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$19.11
-23.4% from high
52-Week Low
$7.94
+84.3% from low
Target vs 52W High
$9.21
-51.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.4%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.7%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +31.4%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +40.7%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%